Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Sandra Möhr

Sandra Möhr

REHAB Basel, Switzerland

Berta Brusilovsky Filer

Berta Brusilovsky Filer

Architect, Spain

Dusan Kuljancic

Dusan Kuljancic

University of Novi Sad, Serbia

Sajitha S

Sajitha S

Cochin University of Science and Technology, India

Johann Lechner

Johann Lechner

Clinic Integrative Dentistry Munich, Germany

Faheem Ahmad Reegu

Faheem Ahmad Reegu

Jazan University, Saudi Arabia

Maria Isabel Garcia-Planas

Maria Isabel Garcia-Planas

Polytechnic University of Catalonia Barcelona Tech Spain

Yewande Okunoren-Oyeken

Yewande Okunoren-Oyeken

United Kingdom of Great Britain and Northern Ireland, UK

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

BRAIN DISORDER- 2024

Welcome Message

Welcome to the BRAIN DISORDER 2024 Conference! We are delighted to invite you to join us this August 05-06, 2024 in Paris, France for an insightful exploration of the latest advancements in neuroscience and brain disorder research. Our conference promises a dynamic platform for experts, researchers, and professionals to share groundbreaking insights, fostering collaboration and innovation in the quest for improved understanding and treatment of neurological conditions. Get ready to engage in stimulating discussions, connect with industry leaders, and contribute to shaping the future of brain health. We look forward to a vibrant exchange of ideas and knowledge at this year's conference!

About Conference


The 5th Global Summit on Brain Disorders and Therapeutics is a premier gathering of leading minds in neuroscience, medicine, and related fields, scheduled to take place on August 05-06, 2024 in Paris, France. This highly anticipated event aims to provide a comprehensive platform for the exchange of cutting-edge research, insights, and innovations in the field of brain disorders.

Attendees can anticipate engaging keynote presentations, interactive discussions, and the opportunity to network with experts and professionals. As we collectively address the challenges associated with neurological conditions, the conference serves as a catalyst for collaboration, pushing the boundaries of knowledge and paving the way for advancements in understanding, diagnosing, and treating brain disorders. Join us in August for a transformative experience at the forefront of brain health research and development.

Sessions and Tracks

Track 1: Brain Diagnosis

Brain diagnosis is a critical medical process that involves a range of methods and tests to identify and understand conditions affecting the brain. Healthcare professionals utilize advanced techniques like neuroimaging, electroencephalography, blood tests, and cognitive assessments to assess brain health. The accurate diagnosis of brain-related disorders is essential for tailoring effective treatment plans, which may include medical, surgical, or therapeutic interventions, depending on the specific condition. Early and precise diagnosis is key to improving outcomes and the overall well-being of individuals with brain-related issues.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 2: Brain Injury and Rehabilitation

Brain injuries can have profound and often long-lasting effects on a person's life. Rehabilitation plays a crucial role in helping individuals recover and regain their independence after a brain injury. It involves a comprehensive approach, including physical therapy, occupational therapy, speech therapy, and neuropsychological interventions, tailored to the individual's specific needs. Rehabilitation aims to improve cognitive functions, motor skills, and overall quality of life for those who have experienced brain injuries, whether due to trauma, stroke, or other causes. It's a challenging and often lengthy process, but it can lead to significant improvements in a person's functional abilities and overall well-being.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 3: Electroconvulsive Therapy

Electroconvulsive therapy (ECT) is a medical procedure used to treat severe mental health conditions, primarily when other treatments have not been effective. It involves the controlled application of electrical currents to the brain, inducing a brief seizure, which is believed to have a therapeutic effect on certain mental disorders, such as severe depression, bipolar disorder, and some forms of schizophrenia. ECT is typically considered when other treatment options, such as medications and psychotherapy, have not provided relief. It is administered under general anesthesia and carefully monitored by healthcare professionals to ensure its safety and effectiveness. ECT has evolved over the years and is now a more refined and well-regulated procedure, but it remains a topic of discussion and debate in the field of mental health treatment due to its potential side effects and ethical considerations.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 4: Neurological Disorders

Neurological disorders are a broad category of medical conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. These disorders can manifest in various ways, leading to a wide range of symptoms such as impaired motor function, sensory disturbances, cognitive deficits, and emotional disturbances. Some common neurological disorders include epilepsy, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and stroke. These conditions can have a significant impact on an individual's quality of life and often require specialized medical care, including neurologists, to diagnose and manage them. Advances in neuroscience and research continue to expand our understanding of these disorders, offering hope for improved treatments and potential cures in the future.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 5: Vagus Nerve Stimulation (VNS)

Vagus Nerve Stimulation (VNS) is a medical treatment that involves the use of an implanted device to stimulate the vagus nerve, a major cranial nerve that plays a crucial role in regulating various bodily functions. VNS is primarily employed as a therapy for epilepsy and treatment-resistant depression, although it's being explored for other conditions like anxiety and chronic pain. By sending electrical impulses to the vagus nerve at regular intervals, VNS can help reduce the frequency and severity of seizures in epilepsy patients and alleviate symptoms of depression in individuals who don't respond well to other treatments. This therapy's exact mechanisms are still under investigation, but it offers a valuable option for those with certain neurological and psychiatric disorders when conventional treatments have proven ineffective.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 6: Neuro-Oncology & Brain Tumors

Neuro-oncology is a specialized field of medicine that focuses on the study and treatment of brain and central nervous system tumors, collectively referred to as brain tumors. These tumors can be either benign or malignant and can originate in the brain tissue itself or spread to the brain from other parts of the body. Brain tumors are a diverse group of diseases, and their management often involves a multidisciplinary approach, including neurosurgeons, neuro-oncologists, radiation oncologists, and other medical specialists. Treatment options for brain tumors may include surgery, radiation therapy, chemotherapy, and targeted therapies. Early diagnosis and treatment are crucial in improving the prognosis for patients with brain tumors, making neuro-oncology a vital field in the battle against these often challenging and life-altering conditions. Ongoing research and advancements in medical technology are continually improving our understanding of brain tumors and expanding the range of available treatment options.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 7: Pediatric Neurology

Pediatric neurology is a specialized medical field focused on the diagnosis and treatment of neurological disorders in children, from infancy to adolescence. Pediatric neurologists are highly trained professionals who address a wide spectrum of conditions, including epilepsy, developmental delays, neuromuscular disorders, and more. They play a crucial role in providing expert care to young patients, helping to improve their neurological health and overall well-being. Their work involves not only clinical practice but also research to advance the understanding and treatment of pediatric neurological conditions, making a significant impact on the lives of children and their families.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 8: Pathophysiology of Brain Disorders

The pathophysiology of brain disorders involves the complex mechanisms underlying the development and progression of various conditions that affect the brain and nervous system. Brain disorders can result from a wide array of factors, including genetic predisposition, environmental influences, infections, trauma, and neurodegenerative processes. These conditions disrupt the normal functioning of the brain, often leading to cognitive, motor, sensory, or emotional impairments. Understanding the pathophysiology of specific brain disorders is essential for accurate diagnosis and effective treatment strategies. Research in this field continually uncovers the intricate molecular, cellular, and physiological changes that occur in disorders like Alzheimer's disease, Parkinson's disease, stroke, and many others, paving the way for the development of targeted therapies and interventions to improve the lives of individuals affected by these challenging conditions.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 9: Deep Brain Stimulation (DBS)

Deep Brain Stimulation (DBS) is a neurosurgical procedure that involves the implantation of a medical device, often referred to as a "brain pacemaker," into specific regions of the brain. This device delivers electrical impulses to modulate neural activity and is primarily used to treat movement disorders such as Parkinson's disease, essential tremor, and dystonia, as well as certain psychiatric conditions like obsessive-compulsive disorder. DBS can provide significant symptom relief for patients who have not responded well to other treatments, and it offers the advantage of adjustability to fine-tune the stimulation parameters as needed. While the exact mechanisms of DBS are not fully understood, it has become an important therapeutic option for improving the quality of life for individuals with these neurological and psychiatric disorders.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 10: Neuropharmacology

Neuropharmacology is a branch of pharmacology that specifically focuses on the study of drugs and their effects on the nervous system. It delves into how various substances, including medications and neurotransmitters, interact with the brain and its intricate network of neurons to influence behavior, mood, and cognitive functions. Neuropharmacologists work to understand the mechanisms of action of drugs and their potential applications in treating neurological and psychiatric disorders. This field plays a vital role in the development of medications for conditions like depression, schizophrenia, epilepsy, and many others, ultimately contributing to advances in the treatment and management of a wide range of neurological and mental health issues.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 11: Brain Cancer & Tumors

Brain cancer and tumors are serious medical conditions that involve the uncontrolled growth of abnormal cells in the brain. These growths can be benign (non-cancerous) or malignant (cancerous). Malignant brain tumors can be particularly aggressive and life-threatening. Common symptoms of brain tumors include headaches, seizures, cognitive changes, and neurological deficits. The treatment approach varies depending on the type, location, and grade of the tumor but often includes surgery, radiation therapy, chemotherapy, and targeted therapies. Early diagnosis and a multidisciplinary approach involving neurosurgeons, oncologists, and other specialists are essential in managing brain tumors effectively. Ongoing research continues to advance our understanding of these conditions, offering hope for improved treatments and outcomes for patients with brain cancer and tumors.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 12: Psychology and Neuroscience

Psychology and Neuroscience are closely related fields that together explore the complex workings of the human mind and brain. Psychology is the scientific study of behavior and mental processes, examining topics such as cognition, emotions, social interactions, and individual differences. In contrast, neuroscience delves into the biological underpinnings of these psychological phenomena, investigating brain structure and function, neural pathways, and how they relate to various aspects of human behavior and experience.

The synergy between these disciplines has led to significant breakthroughs in our understanding of the mind-brain connection. For example, neuroimaging techniques like fMRI and EEG allow researchers to visualize brain activity during psychological tasks, providing insights into the neural basis of behavior and mental disorders. This interdisciplinary approach has enriched both fields, deepening our comprehension of human nature and contributing to advancements in psychology and neuroscience, leading to improved treatments for various mental health conditions.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 13: Mental Disorder / Mental Illness / Psychiatric Disorders

Mental disorders, also known as mental illnesses or psychiatric disorders, are medical conditions that affect an individual's thoughts, emotions, behavior, and overall mental well-being. These conditions encompass a wide spectrum of disorders, including anxiety disorders, mood disorders, psychotic disorders, and more. Mental disorders can have a profound impact on a person's daily life, relationships, and overall functioning. They often arise from a complex interplay of genetic, environmental, and psychological factors. Treatment for mental disorders may involve therapy, medication, lifestyle changes, or a combination of these approaches. Reducing stigma, increasing awareness, and improving access to mental healthcare are vital steps in addressing the challenges posed by mental disorders and supporting those who experience them in leading fulfilling lives.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 14: Neuroinformatics and Computational Neuroscience

Neuroinformatics and computational neuroscience represent two interconnected fields at the intersection of neuroscience, computer science, and data analysis. Neuroinformatics involves the development and application of computational tools and databases to manage, analyze, and share complex neuroscience data, facilitating collaboration and discovery in the field. Computational neuroscience, on the other hand, focuses on creating mathematical models and simulations of the brain's structure and function, aiming to unravel the neural mechanisms underlying cognitive processes and behaviors. These two fields work together, with neuroinformatics providing the infrastructure and computational tools necessary for managing and interpreting the vast amounts of data generated by neuroscience research, while computational neuroscience seeks to formulate theories and models that can explain brain function and behavior. Their combined efforts drive progress in understanding the brain, making strides in areas like neural network modeling, brain mapping, and the development of potential treatments for neurological and psychiatric disorders.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 15: Human Brain Mapping

Human Brain Mapping is a multidisciplinary field that involves the use of various neuroimaging techniques to explore the structure and function of the human brain. This includes technologies like fMRI, PET scans, EEG, and others to create detailed maps of the brain's activity and connectivity. These maps provide critical insights into how different regions of the brain are involved in various cognitive functions, emotions, and sensory processing. Human brain mapping is instrumental in advancing our understanding of neurological and psychiatric disorders, helping to identify abnormalities and develop potential treatments. It also plays a vital role in the study of normal brain development and the neural basis of complex human behaviors, contributing to both basic neuroscience research and clinical applications in the field of medicine.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 16: Excitotoxic Cell Damage

Excitotoxic cell damage is a pathological process in which nerve cells (neurons) are damaged or killed as a result of excessive and prolonged stimulation by excitatory neurotransmitters, such as glutamate. While these neurotransmitters are crucial for normal brain function and communication between neurons, an overabundance can lead to harmful effects. Excitotoxicity can occur in various neurological conditions, including strokes, traumatic brain injuries, and neurodegenerative diseases like Alzheimer's and Parkinson's. It involves the excessive activation of receptors on neurons, leading to an influx of calcium ions and other harmful processes that ultimately result in cell death. Researchers and clinicians are continually studying excitotoxicity to develop strategies and medications that can mitigate its damaging effects, potentially offering new avenues for the treatment of neurological disorders.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 17: Stem Cell Therapies

Stem cell therapies are a promising and rapidly evolving field in regenerative medicine, holding significant potential for treating a variety of medical conditions. Stem cells are undifferentiated cells with the unique ability to develop into different cell types in the body. These therapies can be used to repair, replace, or regenerate damaged or diseased tissues and organs. While stem cell treatments have shown great promise for conditions like heart disease, spinal cord injuries, and certain types of cancer, the field is still undergoing extensive research and clinical trials to establish their safety and effectiveness. Ethical and regulatory considerations also play a significant role in the development and use of stem cell therapies, and the field continues to evolve as we gain a deeper understanding of these remarkable cells and their applications in modern medicine.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 18: Alzheimer’s and Parkinson’s Diseases

Alzheimer's and Parkinson's diseases are two common neurodegenerative disorders, both with distinct characteristics and impacts on patients. Alzheimer's disease is primarily characterized by progressive memory loss, cognitive decline, and behavioral changes. It results from the accumulation of abnormal protein deposits in the brain, such as beta-amyloid plaques and tau tangles. On the other hand, Parkinson's disease is marked by motor symptoms, including tremors, rigidity, and bradykinesia, caused by the degeneration of dopamine-producing neurons in the brain. Although the exact causes of these diseases are not fully understood, research into their underlying mechanisms and potential treatments is ongoing. Early diagnosis and appropriate medical care can help improve the quality of life for those affected by these conditions, and ongoing research offers hope for more effective therapies and interventions in the future.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 19: Neurosurgery

Neurosurgery is a specialized field of medicine dedicated to the diagnosis, treatment, and surgical management of disorders affecting the nervous system, including the brain, spinal cord, and peripheral nerves. Neurosurgeons are highly trained medical professionals who perform intricate surgical procedures to address conditions like brain tumors, spinal injuries, vascular malformations, and degenerative spinal disorders. These surgical interventions often require a high level of precision and expertise to minimize damage to delicate neural structures. Neurosurgery plays a critical role in improving the lives of patients facing neurological disorders and is often combined with other medical and therapeutic approaches to provide comprehensive care. Advances in technology and techniques continue to expand the possibilities for successful surgical interventions and improved outcomes for individuals with complex neurological conditions.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 20: Novel Treatment Strategies

Novel treatment strategies represent innovative and often unconventional approaches to address medical conditions and diseases. These approaches can involve the use of cutting-edge technology, the repurposing of existing drugs for new applications, or the development of entirely new therapies based on a deeper understanding of disease mechanisms. Novel treatments offer the potential to improve patient outcomes, especially in cases where conventional therapies have limitations or have shown limited efficacy. Medical researchers and clinicians continually explore these strategies to push the boundaries of healthcare, and their success can lead to breakthroughs in managing conditions like cancer, infectious diseases, rare genetic disorders, and various other health challenges. Embracing and supporting the development of novel treatment strategies is essential for advancing the field of medicine and ultimately enhancing the well-being of patients.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 21: Addiction & Brain Disorders

Addiction is a complex and often devastating condition that intersects with the realm of brain disorders. It involves the compulsive use of substances or engagement in behaviors despite harmful consequences. Research has shown that addiction fundamentally alters brain structure and function, particularly in areas related to reward, motivation, and decision-making. Substance abuse can lead to neurochemical imbalances, causing a person to crave the substance and experience withdrawal symptoms. The recognition of addiction as a brain disorder has shifted the approach to treatment, emphasizing the need for evidence-based interventions that address both the physical and psychological aspects of addiction. Understanding the neural mechanisms underlying addiction is crucial for developing effective prevention and treatment strategies to help individuals break free from the cycle of addiction and regain control of their lives.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Track 22:  Mental Retardation

Mental retardation, now commonly referred to as intellectual disability, is a condition characterized by limitations in intellectual and adaptive functioning. Individuals with intellectual disabilities may have difficulties with learning, problem-solving, reasoning, and adapting to everyday life. These limitations often become evident during childhood and can vary in severity, from mild to profound. Intellectual disability is a diverse condition with numerous potential causes, including genetic factors, prenatal exposure to toxins, infections, or other developmental issues. Early diagnosis and intervention are essential to provide appropriate support and educational resources to individuals with intellectual disabilities, helping them lead fulfilling lives and achieve their maximum potential. Society's understanding and acceptance of intellectual disability have evolved, with an emphasis on promoting inclusion, independence, and a respectful approach to individuals with these conditions.

Brain Disorder 2024 | Neuroscience Conferences | Mental Retardation Conference | Novel Treatment Strategies | Stem Cell Therapies | Brain Disorder Conferences | Neuroinformatics and Computational Neuroscience | Human Brain Mapping Events | Brain Injury and Rehabilitation Meet

Related Organizations:

American Neuropsychiatric Association | British Neuroscience Association | European Brain and Behaviour Society | Federation of European Neuroscience Societies | International Brain Research Organization | Japan Society of Neurovegetative Research | Neuronus IBRO & IRUN Neuroscience Forum | Society for Neuroscience | UCL Neuroscience

Why to attend?

  1. Knowledge Enrichment: Access cutting-edge research, advancements, and insights in the field of brain disorders, expanding your understanding.
  2. Networking Opportunities: Connect with leading professionals, researchers, and experts to foster collaborations and potential partnerships.
  3. Skill Development: Attend workshops and sessions to enhance your skills and stay abreast of the latest methodologies and technologies.
  4. Feedback and Validation: Present your work to receive valuable feedback, validation, and constructive criticism from peers and experts.
  5. Career Advancement: Explore career opportunities, stay updated on industry trends, and gain exposure to potential employers or collaborators.
  6. Publication Opportunities: Participate in discussions and research presentations that may lead to publication opportunities, increasing the visibility of your work.

Who Should Attend

  1. Researchers and Scientists: Stay informed about the latest research findings and methodologies in brain disorder studies.
  2. Clinicians and Practitioners: Gain insights into new diagnostic and treatment approaches, improving patient care.
  3. Academics and Educators: Stay updated on educational strategies and research, enhancing teaching methods.
  4. Industry Professionals: Discover innovations and potential partnerships, contributing to the development of products and services related to brain disorders.
  5. Students: Learn from experts, connect with mentors, and explore potential career paths in the field of neuroscience and brain disorders.
  6. Policy Makers: Stay informed about the latest developments in brain disorder research to make informed policy decisions.
  7. Patient Advocates: Engage with the scientific community, learn about advancements, and contribute to discussions on improving patient care and support.

Benefit of Participation

Benefits for Speaker

  • Gain global recognition for your research profile worldwide.
  • Earn professional credits to support your career advancement.
  • Stay updated with the latest advancements in cutting-edge research.
  • Foster lasting connections through social and networking events.
  • Promote your research effectively through a one-page ad featured in abstract books and flyers, reaching a million views and significantly enhancing your research profile.
  • Expand your knowledge beyond your core field of Brain Disorders and Therapeutics by exploring new subjects and areas of study.
  • Experience a unique blend of networking, learning, and enjoyable interactions, all in one comprehensive package.

Benefits for Delegate

  • Enhance your professional development by deepening your understanding and knowledge.
  • Your involvement contributes to the development of innovative methodologies and ideologies that can expand business and industry outcomes.
  • Connect with fellow Brain Disorders and Therapeutics summit researchers and experts, fostering opportunities to exchange fresh ideas and insights within the field.

Benefit for Sponsor

  • Immerse yourself in an international environment to enhance the potential for new company opportunities.
  • Showcase your company's latest technologies, new products, or services to a diverse global audience.
  • Boost your business growth by generating leads through active participation.
  • Building a successful company requires considerable time, effort, and determination. It's invaluable to have a network of colleagues and associates who share a common drive and objective to draw inspiration from.
  • Evaluate and advance your organizational strategies by benchmarking against leading industry plans.
  • Gain valuable insights and solutions to your company's questions and challenges through feedback from trusted experts during our webinars.
  • Elevate your company's branding and marketing through prominent placement of your company's logo on our banners, website, and other event materials.

Benefit for Collaborators

  • This is the premier platform globally for showcasing Brain Disorders and Therapeutics to an extensive audience.
  • Cultivate enduring professional relationships.
  • Elevate your subscriber/member base by 40% through strategic placement of your organization's branding, marketing materials, promotional content, and logo on our banners, website, and event materials.
  • Listing your company in the Global Business forum will significantly amplify its exposure through our event.
  • Your representatives can engage in valuable networking opportunities to enhance their knowledge and understanding of your organization's services and offerings alongside key delegates.
  • Brain Disorders and Therapeutics advertising materials, including posters, brochures, pamphlets, and services, will be seamlessly integrated with information and distributed to hospitals, universities, societies, and researchers.

Market Analysis

The Global Neuroscience market is projected to experience a moderate growth rate in the upcoming years, with a compound annual growth rate (CAGR) of 4.2 percent expected until 2026, reaching a valuation of $721 billion. It is important to note that CAGR estimates may be influenced by high-value segments, giving more weight to larger segments and potentially masking variations among different segments. In reality, the 4.2 percent CAGR observed could conceal substantial differences across segments. Notably, calculated growth projections range from the rapidly expanding digital health segment with a CAGR of 27.8 percent to the slower-growing behavioral therapy services segment with a CAGR of 3.5 percent.

In 2022, revenue generated for the diagnosis of brain disorders amounted to a total of $7.9 billion. Of this, 83 percent came from non-molecular diagnostic solutions, such as electrophysiology and imaging techniques like electroencephalogram (EEG) or MRI, while the remaining 17 percent stemmed from molecular counterparts like PCR and immunoassay (figure 5).

The molecular segment is anticipated to experience growth 2.5 times greater than the non-molecular segment, with respective compound annual growth rate (CAGR) values of 17 percent and 7 percent. Forecasts predict that the neuroscience diagnostic market will expand at a CAGR of 8.9 percent, reaching a valuation of $11.1 billion by 2026.

- Digital health and molecular diagnostics: Currently valued below $4 billion, these segments are forecasted to experience rapid growth with compound annual growth rates (CAGR) of 27.8 percent and 17 percent, respectively, reaching $9.6 billion and $2.6 billion by 2026.

- Behavioural therapy services: Holding the largest revenue share at $441.1 billion, this segment anticipates the lowest growth rate with a CAGR of 3.5 percent.

- Drugs and non-molecular diagnostics: These segments currently generate intermediate revenue levels ranging from $7 billion to $99 billion, with modest growth projections between 4.8 to 7 percentage points.

To Collaborate Scientific Professionals around the World

Conference Date August 05-06, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

International Journal of Mental Health & Psychiatry journal of Neuroscience & Clinical Research

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Alzheimer's Disease
  • Brain And Behavior
  • Brain Circuits
  • Brain Connectivity
  • Brain Disorders
  • Brain Disorders Epidemiology
  • Brain Health
  • Brain Imaging
  • Brain Injuries
  • Brain Mapping
  • Brain Stimulation
  • Brain-Derived Neurotrophic Factor
  • Brain-Gut Axis
  • Cognitive Aging
  • Cognitive Behavioral Therapy
  • Cognitive Enhancement
  • Cognitive Impairment
  • Cognitive Remediation
  • Computational Neuroscience
  • Deep Brain Stimulation
  • Epilepsy
  • Functional Neuroimaging
  • Gene Therapy
  • Mental Health Disorders
  • Molecular Therapeutics
  • Neural Plasticity
  • Neuro-oncology
  • Neuro-ophthalmology
  • Neurobehavioral Disorders
  • Neurobiology
  • Neurobiology Of Addiction
  • Neurochemistry
  • Neurocircuitry
  • Neurocognitive Disorders
  • Neurodegeneration
  • Neurodegenerative Therapies
  • Neurodevelopmental Disorders
  • Neurodevelopmental Therapeutics
  • Neuroembryology
  • Neuroendocrinology
  • Neuroengineering
  • Neuroethics
  • Neurofeedback
  • Neurogenesis
  • Neurogenetics
  • Neuroimmune Disorders
  • Neuroimmunology
  • Neuroinfectious Diseases
  • Neuroinflammation
  • Neuroinformatics
  • Neuroinformatics Tools
  • Neurological Biomarkers
  • Neurological Biomaterials
  • Neurological Clinical Trials
  • Neurological Diagnostics
  • Neurological Diseases
  • Neurological Disorders
  • Neurological Examination
  • Neurological Genetics
  • Neurological Intensive Care
  • Neurological Pharmacogenomics
  • Neurological Rehabilitation
  • Neurological Surgery
  • Neuromodulation
  • Neuromuscular Disorders
  • Neuropathic Pain
  • Neuropathology
  • Neuropharmacokinetics
  • Neuropharmacology
  • Neurophotonics
  • Neuroprotection
  • Neuropsychiatric Conditions
  • Neuropsychiatric Genetics
  • Neuropsychiatric Rehabilitation
  • Neuropsychiatry
  • Neuropsychology
  • Neuropsychopharmacology
  • Neuroregeneration
  • Neurorehabilitation
  • Neurosensory Disorders
  • Neurosurgery
  • Neurosurgical Innovations
  • Neurotechnology
  • Neurotheranostics
  • Neurotherapeutics
  • Neurotoxicology
  • Neurotransmitters
  • Neurovirology
  • Parkinson's Disease
  • Pharmacotherapy
  • Precision Medicine
  • Psychiatric Disorders
  • Psychoneuroendocrinology
  • Psychoneuroimmunology
  • Psychosocial Interventions
  • Psychotropic Medications
  • Stem Cell Therapy
  • Stroke
  • Therapeutic Targets